RENAISSANCE TECHNOLOGIES LLC
Position in DMAC — DiaMedica Therapeutics Inc.
CIK 1037389
NEW YORK, NY
Position in DMAC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$355,580
+$256,883 QoQ
Shares Held
52,523
-18.6% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in DMAC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $355,580 | 52,523 | Shares | Sole | 2026-05-14 | |
| 2023-03-31 | $98,697 | 64,508 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $53,121 | 33,619 | Shares | Sole | 2023-02-13 | |
| 2021-06-30 | $418,745 | 94,100 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,400,865 | 153,100 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,149,876 | 113,400 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $407,040 | 96,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $725,571 | 104,700 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $72,377 | 25,849 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||